Home Table of Contents

§ 3999.22. Medication Assisted Treatment for Substance Abuse Disorders Pilot Program.

15 CA ADC § 3999.22Barclays Official California Code of Regulations

Barclays California Code of Regulations
Title 15. Crime Prevention and Corrections
Division 3. Adult Institutions, Programs and Parole
Chapter 1. Rules and Regulations of Adult Operations and Programs (Refs & Annos)
Subchapter 8. Pilot Programs
Article 1. Pilot Programs
15 CCR § 3999.22
§ 3999.22. Medication Assisted Treatment for Substance Abuse Disorders Pilot Program.
Currentness
Memorandum
Date: March 13, 2017
To:
Executive Leadership
Deputy Directors
California Correctional Health Care Services
Executive Leadership
Division of Health Care Services
Louie Escobell, Chief Executive Officer
Muhammad Farooq, M.D., MBA, MPH, Chief Medical Executive
Alex Serrano, RN, Chief Nurse Executive
Victor Jordan, Ph.D., Chief of Mental Health
California Institution for Men
James Elliot, MA, CCHP, Chief Executive Officer
Leslie Taylor, M.D., Chief Medical Executive
Nyreith Adeyemi, MBA, BSN, RN, PHN, Chief Nurse Executive
Michael Hewitt, Psy.D, Chief of Mental Health
California Institution for Women
From:
Diana L. Toche, D.D.S., Undersecretary
Health Care Services
California Department of Corrections and Rehabilitation
Richard Kirkland
Chief Deputy Receiver
Subject:
Medication Assisted Treatment for Substance Abuse Disorders Pilot Program
This memorandum constitutes certification, pursuant to Penal Code (PC) section 5058.1, subdivision (b)(2), for California Correctional Health Care Services (CCHCS) and the California Department of Corrections and Rehabilitation (CDCR) to proceed with a Medication Assisted Treatment for Substance Abuse Disorders Pilot Program (Pilot). Senate Bill (SB) 843 was enacted with the adoption of Chapter 33, Statutes of 2016 which adds PC section 2694.5 and requires the CDCR to establish a Pilot program at one or more institutions that will provide a medication assisted treatment model for inmates with a history of substance abuse problems. SB 826, Chapter 23, Statutes of 2016 appropriated $2,500,000 in funding to be used to develop the Pilot.
PILOT PROJECT LOCATIONS
The Pilot will be conducted at California Institution for Men and California Institution for Women.
PILOT PROJECT DURATION
The Pilot will be in effect for three years and will expire by operation of law at the end of this period unless it is promulgated through the Administrative Procedure Act prior to expiration.
PILOT OVERVIEW
The Pilot shall offer a continuum of evidence-based care that is designed to meet the needs of the individuals being served and that is appropriate for a correctional setting. In establishing the Pilot, pursuant to SB 843, CDCR is required to consider the following:
1. Access to services during a patient's enrollment in the pilot program;
2. Access to subacute detoxification and medical detoxification, as necessary;
3. Comprehensive pre-treatment and post-treatment assessments;
4. Ongoing evaluation of a patient's program needs and progress at least every 90 days, and appropriate adjustment of treatment based on that evaluation;
5. Services provided by professionals for whom substance use disorder treatment is within the scope of their practice;
6. Referrals for medication assisted care and prescription of medication assisted treatment;
7. Provision of behavioral health services, including the capacity to treat co-occurring mental illness;
8. Access to medication assisted treatment throughout the period of incarceration up to and including immediately prior to release; and
9. Linkages to community-based treatment upon parole.
FISCAL IMPACT
SB 826 appropriated $2,500,000 in funding to be used to develop the Pilot. The funding is available for encumbrance or expenditure until June 30, 2019.
REPORTING REQUIREMENTS
SB 843 requires CDCR to report to the fiscal and appropriate policy committees of the Legislature by March 1, 2017, and each March thereafter during the tenure of the Pilot. The report shall include the following elements:
1. The planned patient capacity of the program;
2. The number of patients enrolled in the program;
3. The number of patients who leave the treatment program against medical advice and the number of patients who are discharged from the program prior to achieving their treatment goals;
4. The percentage of patients with negative urine toxicology screens for illicit substances during treatment and post-treatment while incarcerated; and
5. The number of patients who are successfully linked to post-release treatment.
CERTIFICATION
We certify that this Pilot qualifies for exemption under Penal Code sections 5058.1 and 2694.5.
cc: Angela Ponciano, Associate Director, Mental Health Program, CDCR
Michael Golding, M.D., Statewide Chief Psychiatrist, Mental Health Program, CDCR
Thomas Gilevich, Assistant Chief Counsel, Office of Legal Affairs, CDCR
Tim Lockwood, Chief, Regulation and Policy Management Branch, CDCR
Jasinda Muhammad, Assistant Deputy Director, Human Resources, CCHCS
Duane Reeder, Associate Director, Fiscal Services, CCHCS
Lara Saich, Chief, Risk Management Branch, CCHCS

Credits

History
1. New section filed 4-3-2017; operative 4-3-2017 pursuant to Penal Code section 5058.1(c). Submitted to OAL for filing with the Secretary of State and printing only pursuant to Penal Code section 5058.1(b) (Register 2017, No. 14). Section shall lapse by operation of law on 4-3-2020 pursuant to Penal Code section 2694.5(a) unless formally adopted as a regulation pursuant to Chapter 3.5 (commencing with section 11340) of Part 1 of Division 3 of Title 2 of the Government Code.
This database is current through 5/10/24 Register 2024, No. 19.
Cal. Admin. Code tit. 15, § 3999.22, 15 CA ADC § 3999.22
End of Document